Details
Table of Contents
Contents: preface
Part I: Medicine and pharmaceutics
1. Patenting biosimilars / Claudia Mund
2. Patenting diagnostics / Dieter Wächter
3. Patenting human genes in Europe- and how it compares to the us and Australia / Timo Minssen
4. Patenting human genes in the United States / Samantak Gosh
5. An exorbitant monopoly: the high court of Australia, myriad genetics, and gene patents / Matthew Rimmer
6. Exclusivity for biologics / Duncan Matthews
Part II: Agricultural sector (crop sciences)
7. Protection of plant innovations / Gert Würtenberger
8. Patenting non transgenic plants in the EU / Michael Kock
9. Non-obvious plants / Mark D. Janis
10. Transgenic plants / James Allred
11. Convention on biological diversity and regulatory law as plant protection / Claudio Chiarolla
12. Patents on native traits: what scope of protection? / Axel Metzger
Part III: Research and development
13. The European Union's IP policy and funding of stem cell research / Aurora Plomer
14. Stem cell patents in the United States / John M Golden
15. Early stage patenting, the U.S. Bayh-Dole act, and the anti-commons hypothesis / Charles R. Mcmanis and Brian Yagi
16. IP in research and development agreements / Melanie Graf and Herbert Zech
17. Patent pools and clearinghouses in the life sciences: back to the future / Geertrui van Overwalle
Part IV: Country case studies in IP and the life sciences
18. Understanding the brazilian patent reform / Pedro Paranaguá
19. IP protection in the life sciences in China / Lin Xiuqin and Zhang Xinfeng
20. Diverse harmonization: Indian example / Srividhya Ragavan
21. Life science research and patents in Japan: a comparative study of life science invention patentability between the japanese and U.S. patent acts / Toshiko Takenaka
22. Intellectual property and the life sciences in Kenya: enforcement and access to medicines / John Harrington
23. IP and life sciences: a case study of South Africa / Tenu Avafia
24. Thailand's compulsory licenses and the increase of investment arbitration / David Degen
Part V: Boundaries of IP and the life sciences
25. Parallel imports within the European Union / Gert Würtenberger
26. Pay for delay agreements / Claudia Seitz
27. Abusive filing of IP rights / Andreas Heinemann
Index.
Part I: Medicine and pharmaceutics
1. Patenting biosimilars / Claudia Mund
2. Patenting diagnostics / Dieter Wächter
3. Patenting human genes in Europe- and how it compares to the us and Australia / Timo Minssen
4. Patenting human genes in the United States / Samantak Gosh
5. An exorbitant monopoly: the high court of Australia, myriad genetics, and gene patents / Matthew Rimmer
6. Exclusivity for biologics / Duncan Matthews
Part II: Agricultural sector (crop sciences)
7. Protection of plant innovations / Gert Würtenberger
8. Patenting non transgenic plants in the EU / Michael Kock
9. Non-obvious plants / Mark D. Janis
10. Transgenic plants / James Allred
11. Convention on biological diversity and regulatory law as plant protection / Claudio Chiarolla
12. Patents on native traits: what scope of protection? / Axel Metzger
Part III: Research and development
13. The European Union's IP policy and funding of stem cell research / Aurora Plomer
14. Stem cell patents in the United States / John M Golden
15. Early stage patenting, the U.S. Bayh-Dole act, and the anti-commons hypothesis / Charles R. Mcmanis and Brian Yagi
16. IP in research and development agreements / Melanie Graf and Herbert Zech
17. Patent pools and clearinghouses in the life sciences: back to the future / Geertrui van Overwalle
Part IV: Country case studies in IP and the life sciences
18. Understanding the brazilian patent reform / Pedro Paranaguá
19. IP protection in the life sciences in China / Lin Xiuqin and Zhang Xinfeng
20. Diverse harmonization: Indian example / Srividhya Ragavan
21. Life science research and patents in Japan: a comparative study of life science invention patentability between the japanese and U.S. patent acts / Toshiko Takenaka
22. Intellectual property and the life sciences in Kenya: enforcement and access to medicines / John Harrington
23. IP and life sciences: a case study of South Africa / Tenu Avafia
24. Thailand's compulsory licenses and the increase of investment arbitration / David Degen
Part V: Boundaries of IP and the life sciences
25. Parallel imports within the European Union / Gert Würtenberger
26. Pay for delay agreements / Claudia Seitz
27. Abusive filing of IP rights / Andreas Heinemann
Index.